<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30610205</article-id>
<article-id pub-id-type="pmc">6609509</article-id>
<article-id pub-id-type="doi">10.1038/s41380-018-0324-x</article-id>
<article-id pub-id-type="manuscript">NIHMS1512779</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An autism-linked missense mutation in <italic>SHANK3</italic> reveals the modularity of Shank3 function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname>
<given-names>Kaifang</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Kihoon</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adamski</surname>
<given-names>Carolyn J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Lingjie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lai</surname>
<given-names>Jason K.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bondar</surname>
<given-names>Vitaliy V</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duman</surname>
<given-names>Joseph G.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Richman</surname>
<given-names>Ronald</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tolias</surname>
<given-names>Kimberley F.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barth</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palzkill</surname>
<given-names>Timothy</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhandong</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holder</surname>
<given-names>J. Lloyd</given-names>
<suffix>Jr</suffix>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>Huda Y.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Human Genetics</aff>
<aff id="A2"><label>2</label>Department of Pediatrics</aff>
<aff id="A3"><label>3</label>Department of Pharmacology</aff>
<aff id="A4"><label>4</label>Department of Neuroscience</aff>
<aff id="A5"><label>5</label>Howard Hughes Medical Institute</aff>
<aff id="A6"><label>6</label>Verna and Marrs McLean Department of Biochemistry and Molecular Biology</aff>
<aff id="A7"><label>7</label>Integrative Molecular and Biomedical Sciences Program</aff>
<aff id="A8"><label>8</label>Structural and Computational Biology and Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="A9"><label>9</label>Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030, USA</aff>
<aff id="A10"><label>10</label>Department of Neuroscience and Division of Brain Korea 21 Biomedical Science, Korea University College of Medicine, Seoul, 02841, South Korea</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence: <email>holder@bcm.edu</email> or <email>hzoghbi@bcm.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>7</month>
<year>2019</year>
</pub-date>
<elocation-id>10.1038/s41380-018-0324-x</elocation-id>
<permissions>
<license>
<license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
</license>
</permissions>
<abstract id="ABS1">
<p id="P1">Genome sequencing has revealed an increasing number of genetic variations that are associated with neuropsychiatric disorders. Frequently, studies limit their focus to likely gene-disrupting mutations because they are relatively easy to interpret. Missense variants, instead, have often been undervalued. However, some missense variants can be informative for developing a more profound understanding of disease pathogenesis and ultimately targeted therapies. Here we present an example of this by studying a missense variant in a well-known autism spectrum disorder (ASD) causing gene <italic>SHANK3</italic>. We analyzed Shank3’s <italic>in vivo</italic> phosphorylation profile and identified S685 as one phosphorylation site where one ASD-linked variant has been reported. Detailed analysis of this variant revealed a novel function of Shank3 in recruiting Abelson interactor 1 (ABI1) and the WAVE complex to the post-synaptic density (PSD), which is critical for synapse and dendritic spine development. This function was found to be independent of Shank3’s other functions such as binding to GKAP and Homer. Introduction of this human ASD mutation into mice resulted in a small subset of phenotypes seen previously in constitutive <italic>Shank3</italic> knockout mice, including increased allogrooming, increased social dominance, and reduced pup USV. Together, these findings demonstrate the modularity of Shank3 function <italic>in vivo</italic>. This modularity further indicates that there is more than one independent pathogenic pathway downstream of Shank3 and correcting a single downstream pathway is unlikely to be sufficient for clear clinical improvement. In addition, this study illustrates the value of deep biological analysis of select missense mutations in elucidating the pathogenesis of neuropsychiatric phenotypes.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1">
<title>INTRODUCTION</title>
<p id="P2">Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterized by impaired social communication, poor language development, repetitive behaviors, and restricted interests. Genome sequencing has revealed an increasing number of genes responsible for ASD by identification of <italic>de novo</italic> likely gene-disrupting (LGD) mutations. Missense mutations, instead, have been considered far less informative because most of them are of unknown significance.</p>
<p id="P3">LGD mutations in <italic>SHANK3</italic> are estimated to contribute to ~1% of all ASD cases <sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref></sup>. Moreover, epigenetic dysregulation of <italic>SHANK3</italic> has been reported in up to 15% of individuals with ASD <sup><xref ref-type="bibr" rid="R4">4</xref></sup>. Thus, <italic>SHANK3</italic> is a well-established autism risk gene, and detailed mechanistic studies provide insights into ASD pathogenesis. Individuals with mutations in <italic>SHANK3</italic> often manifest intellectual disability, autism, hypotonia, and motor delay <sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>. Shank3 serves as a scaffolding protein within the postsynaptic density (PSD) of dendritic spines, which are actin-rich protrusions from dendrites <sup><xref ref-type="bibr" rid="R7">7</xref></sup>. The protein has a PSD95/discs large/ZO-1 (PDZ) domain that binds guanylate kinase-associated proteins (GKAPs), which further bridge Shank3 to PSD-95, another major scaffold in the PSD <sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Shank3 also has a large proline-rich domain containing ABI1, IRSp53, Homer and cortactin binding motifs <sup><xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R11">11</xref></sup>. Knock down or knockout (KO) of <italic>Shank3</italic> reduces dendritic spine density and maturation <sup><xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup>, whereas overexpression of <italic>Shank3</italic> enhances spine development <sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R19">19</xref></sup>. Most excitatory synapses are built on dendritic spines. As expected, loss of <italic>Shank3</italic> causes excitatory synaptic transmission deficits <sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R20">20</xref>–<xref ref-type="bibr" rid="R27">27</xref></sup>. Such synaptic dysfunction further leads to abnormal behaviors including altered social interaction, motor coordination deficits and repetitive behaviors in <italic>Shank3</italic> KO mouse models <sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R25">25</xref>–<xref ref-type="bibr" rid="R27">27</xref></sup>.</p>
<p id="P4">Efforts have been made to elucidate the underlying molecular mechanisms for developing targeted treatments for individuals with ASD due to a <italic>SHANK3</italic> mutation. Multiple pathways, including CLK2, <italic>I</italic><sub><italic>h</italic></sub> channel, mGluR5, and PAK signaling have been reported to be dysregulated upon loss of Shank3 in model systems <sup><xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R31">31</xref></sup>. However, it is unknown if individual dysregulated molecular pathways are independently responsible for a subset of physiological and behavioral phenotypes. If so, this would represent a modularity to Shank3 function. This information is particularly important regarding targeted treatment of SHANKopathies because if phenotypes are indeed independently mediated by distinct modules of Shank3 function, correcting a single downstream molecular defect is unlikely to be sufficient for improving all the symptoms. A modularity of Shank3 function has not been investigated because most, if not all, studies were done using <italic>Shank3</italic> heterozygous or homozygous null models. Although these models retain construct validity of LGD mutations, it is difficult to pinpoint the specific contribution of each pathway due to the confounding effects of other dysregulated pathways in the same model. To understand the functional modularity of Shank3, missense variants, each only affecting one residue, could be informative.</p>
<p id="P5">Here, by analyzing a missense variant of <italic>SHANK3</italic> found in an individual with autism, we identify a downstream effector that interacts with Shank3 in a phosphorylation-dependent manner. We describe generation and characterization of a knock-in (KI) mouse model of this variant with this interaction specifically disrupted. Using this model, we further determine how this effector and its associated pathway mediate a subset of SHANKopathy phenotypes. We demonstrate the modularity of Shank3 function <italic>in vivo</italic> and highlight the value of studying missense mutations in autism.</p>
</sec>
<sec id="S2">
<title>MATERIALS AND METHODS</title>
<sec id="S3">
<title>Reagents and resources</title>
<p id="P6">For resources such as antibodies and primers, please see <xref ref-type="supplementary-material" rid="SD8">Supplementary Table 8</xref> for more information.,</p>
<p id="P7">A detailed description of the materials and methods is provided in <xref ref-type="supplementary-material" rid="SD10">Supplementary Information</xref>.</p>
</sec>
</sec>
<sec id="S4">
<title>RESULTS</title>
<sec id="S5">
<title>Phosphorylation of Shank3 at S685 modulates its interaction with ABI</title>
<p id="P8">Phosphorylation is a common regulatory mechanism to control key protein-effector interactions, and Shank3 phosphorylation has been reported before <sup><xref ref-type="bibr" rid="R32">32</xref></sup>. Therefore, to identify direct downstream effectors of Shank3, we first examined the phosphorylation state of Shank3 <italic>in vivo</italic>. As no commercial Shank3 antibody consistently worked for immunoprecipitation, we generated a <italic>2×Flag-Shank3</italic> transgenic mouse to efficiently purify Shank3 <italic>in vivo</italic> (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 1a</xref>). We characterized the 2×Flag-tagged Shank3 and found that it, like endogenous Shank3, was enriched in synaptic fractions (P2 and PSD I) (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 1b</xref>). The regional and temporal expression pattern of 2×Flag-Shank3 paralleled those of endogenous Shank3 (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 1c,d</xref>). Compared with wild-type (WT) mice, the transgenic mice had a 1.4-fold greater abundance of the α isoform and a 1.3-fold more in total Shank3 in the crude synaptosomal fraction (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 1e</xref>).</p>
<p id="P9">We immunoprecipitated 2×Flag-Shank3 with an anti-Flag antibody from the cortex, hippocampus, and striatum of the transgenic mice (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 1f</xref>). Immunoprecipitation followed by mass spectrometry analysis identified 41 phosphorylated residues of Shank3 <italic>in vivo</italic> (<xref ref-type="fig" rid="F1">Figure 1a</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). We next evaluated whether any phosphorylated residues are in close proximity to known Shank3 protein-binding domains/motifs. We found that the phosphorylated site S685 is adjacent to a previously identified proline-rich motif (PRM) that is responsible for Shank3 interaction with the SH3 domain of ABI1, an indispensable subunit of the WAVE regulatory complex (WRC) <sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup> (<xref ref-type="fig" rid="F1">Figure 1b</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2a</xref>). To further confirm that phosphorylation at S685 occurs <italic>in vivo</italic>, we generated a phospho-specific antibody to S685 (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2b</xref>). This antibody recognized purified Shank3 from mouse brain but failed to recognize Shank3 after it was treated with phosphatase (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2c</xref>). Given S685’s high degree of conservation among vertebrates (<xref ref-type="fig" rid="F1">Figure 1c</xref>), we considered it highly likely to have functional importance.</p>
<p id="P10">To determine whether phosphorylation of S685 modulates the Shank3-ABI interaction, we performed a co-immunoprecipitation assay in HEK293T cells. Consistent with previous findings <sup><xref ref-type="bibr" rid="R10">10</xref></sup>, ABI1 co-immunoprecipitated with WT Shank3 (<xref ref-type="fig" rid="F1">Figure 1d</xref>). Mutation of the S685 residue of Shank3 to a non-phosphorylatable alanine (S685A) caused significantly less ABI1 to co-immunoprecipitate with Shank3 (<xref ref-type="fig" rid="F1">Figure 1d</xref>). The S685A mutation also decreased the interaction between Shank3 and the ABI1 homolog ABI2, to a similar extent (<xref ref-type="fig" rid="F1">Figure 1e</xref>). These results suggest that S685 phosphorylation is important for the Shank3-ABI interaction.</p>
<p id="P11">We next sought to identify kinases that can phosphorylate Shank3 at S685. We expanded our previously published datasets of the Shank3 interactome <sup><xref ref-type="bibr" rid="R17">17</xref></sup> by new immunoprecipitation-mass spectrometry experiments and public data curation, which resulted in a more comprehensive Shank3 interactome consisting of 793 proteins (see <xref ref-type="sec" rid="S2">Methods</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 2</xref>). We identified 30 kinases among the 793 interactors. To narrow the list of candidate kinases, we searched the literature for their expression patterns and functions, which led us to four candidate kinases: Extracellular signal-regulated kinase 2 (ERK2), Protein kinase A alpha catalytic subunit (PKAα), Glycogen synthase kinase 3 beta (GSK3β), and Casein kinase 2 (CK2). Because its large size makes full-length Shank3 difficult to purify from bacteria, we purified a partial fragment of Shank3 (fragment 4, aa 668–858) that included Shank3 PRM from bacteria, and used it in an <italic>in vitro</italic> kinase assay (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2d</xref>). Mass spectrometry analysis of the kinase reaction products showed that ~97% of all peptides covering S685 were phosphorylated by PKAα (<xref ref-type="fig" rid="F1">Figure 1f</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2e</xref>), and S685 is located within a consensus PKA phosphorylation motif (RXXS/T) <sup><xref ref-type="bibr" rid="R34">34</xref></sup>. None of the other three kinases phosphorylated this site. Co-immunoprecipitation using the striatal tissue of <italic>EGFP-Shank3</italic> transgenic mice revealed that Shank3 and PKAα interacted with each other (<xref ref-type="fig" rid="F1">Figure 1g</xref>). To further validate our mass spectrometry findings, we performed a second kinase assay using synthesized Shank3 peptides (aa 668–691) conjugated with BSA and radiolabeled ATP (see <xref ref-type="sec" rid="S2">Methods</xref>). We found that PKAα phosphorylated WT peptides, while the negative control (BSA alone) and S685A mutant peptides were not phosphorylated (<xref ref-type="fig" rid="F1">Figure 1h</xref>). To examine whether PKA modulates Shank3-ABI interaction in neurons, we performed co-immunoprecipitation using dissociated cortical neurons while blocking PKA activity. Application of small molecule inhibitor H89 inhibited PKA in cortical neurons, as indicated by a decrease in CREB S133 phosphorylation (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 2f</xref>). Inhibition of PKA reduced the amount of Shank3 co-immunoprecipitated with ABI1, while not altering ABI1’s interaction with WAVE1, the core subunit of WRC (<xref ref-type="fig" rid="F1">Figure 1i</xref>). Together, these findings suggest that phosphorylation of S685 of Shank3 by PKA modulates Shank3-ABI interaction.</p>
</sec>
<sec id="S6">
<title>An autism-linked S685I mutation specifically diminishes Shank3-ABI interaction</title>
<p id="P12">Because <italic>SHANK3</italic> haploinsufficiency is strongly linked to ASD, we sought mutations in or around S685 that occur in ASD individuals. An existing ASD database, the Autism Sequencing Consortium, reported several missense mutations in <italic>SHANK3</italic> in autistic individuals <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. We found a G&gt;T substitution at chromosome 22: 51,144,527 (hg build 19), which resulted in an S686I (S685 in mouse) missense mutation. S686I has not been observed in the gnomAD database of over 120,000 individuals without neurologic diseases, indicating it is not a common variant <sup><xref ref-type="bibr" rid="R36">36</xref></sup>. Moreover, both Polyphen-2 and SIFT mutation analysis algorithms predicted this mutation to be damaging to Shank3 function (<xref ref-type="supplementary-material" rid="SD5">Supplementary Table 5</xref>) <sup><xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R38">38</xref></sup>.</p>
<p id="P13">We tested whether the S685I mutation could alter Shank3-ABI interaction. In a co-immunoprecipitation assay, the S685I mutation diminished Shank3 interaction with ABI1 by at least 75% (<xref ref-type="fig" rid="F2">Figure 2a</xref>). The S685I substitution had a similar effect on Shank3-ABI2 interaction (<xref ref-type="fig" rid="F2">Figure 2b</xref>). It is worth noting that S685I did not alter Shank3 interaction with several other well-known binding partners, including cortactin, GKAP, Homer, and IRSp53 (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 3a-d</xref>).</p>
<p id="P14">To better understand the effect of the S685I mutation, we performed kinetic analysis using surface plasmon resonance (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 3e</xref>). Analysis of the binding curves of Shank3 fragment 4 with full-length recombinant ABI1 indicated that the S685I mutation significantly decreased the on-rate constant and caused a ~4-fold increase in the dissociation constant (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 3f</xref>). Thus, the autism-linked Shank3 S685I variant appears to specifically disrupt Shank3-ABI interaction by changing a critical amino acid in the interacting motif.</p>
</sec>
<sec id="S7">
<title>Loss of Shank3-ABI interaction causes altered social behaviors</title>
<p id="P15">To validate our findings and understand the functional importance of Shank3-ABI interaction <italic>in vivo</italic>, we generated KI mice with the S685I substitution (<xref ref-type="fig" rid="F2">Figure 2c,d</xref>). Both heterozygous KI (KI-HET) and homozygous KI (KI-HOM) mice are viable and fertile. They also have a similar body weight compared with WT mice (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 4a</xref>). In addition, both protein abundance and isoform-specific expression pattern of S685I Shank3 were not changed compared with WT control (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 4b</xref>).</p>
<p id="P16">Next, to confirm that S685I mutation disrupts Shank3-ABI interaction <italic>in vivo</italic>, we performed a co-immunoprecipitation assay in KI mice. As expected, significantly less Shank3 was co-immuoprecipitated with ABI1 in the cortex of KI-HET and KI-HOM mice compared with WT mice, with KI-HOM showing more prominent effect (<xref ref-type="fig" rid="F2">Figure 2e</xref>). A similar reduction in Shank3-ABI1 co-immunoprecipitation was observed in the striatum (<xref ref-type="fig" rid="F2">Figure 2f</xref>). In addition, Shank3-GKAP and Shank3-Homer interactions were not affected (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 4c,d</xref>). These results indicate that S685I mutation specifically disrupts Shank3’s interaction with ABI1 <italic>in vivo</italic>.</p>
<p id="P17">Because S685I mutation is linked to autism, we next asked whether there are any social deficits in KI mice. We first tested sociability by the three-chamber test <sup><xref ref-type="bibr" rid="R17">17</xref></sup>. Both WT and KI mice showed a significant preference for a stranger mouse to a novel object (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 4e</xref>), indicating normal sociability.</p>
<p id="P18">To determine if there are any specific abnormal social behaviors other than sociability in KI mice, we performed a resident-intruder assay using stranger C57BL/6J mice as intruders <sup><xref ref-type="bibr" rid="R39">39</xref></sup>. We quantified three categories of social behaviors: active social behavior (sniffing/allogrooming), threatening behavior (mounting), and aggressive behavior (attacking/biting). While there was no difference in threatening and aggressive behaviors, we found an increase in sniffing/allogrooming behavior in KI-HOM mice (<xref ref-type="fig" rid="F2">Figure 2g-i</xref>). The continuous moving and escaping of the C57 intruders made it difficult to differentiate allogrooming from sniffing. Thus, we repeated the assay using submissive A/J mice as intruders <sup><xref ref-type="bibr" rid="R40">40</xref></sup>. We found that KI-HOM mice displayed a robust increase in allogrooming behavior on A/J intruders (<xref ref-type="fig" rid="F2">Figure 2j</xref> and <xref ref-type="supplementary-material" rid="SD11">Supplementary Video 1</xref> and <xref ref-type="supplementary-material" rid="SD12">2</xref>).</p>
<p id="P19">Excessive allogrooming behavior has been associated with increased social dominance <sup><xref ref-type="bibr" rid="R41">41</xref></sup>. To evaluate social dominance, we performed the tube test. In this test, the dominant mouse will push its opponent out of the tube and “win” the match <sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup>. We found that both male and female KI-HOM mice won most of the matches when tested against their WT opponents (<xref ref-type="fig" rid="F2">Figure 2k</xref>), indicating increased social dominance. Only male KI-HET mice displayed the same phenotype (<xref ref-type="fig" rid="F2">Figure 2k</xref>).</p>
<p id="P20">Social communication deficit is another major feature of ASD, especially those caused by mutations in <italic>SHANK3</italic>. To evaluate social communication phenotype in KI mice, we performed isolation-induced pup ultrasonic vocalization (USV) recording. As previously reported <sup><xref ref-type="bibr" rid="R43">43</xref></sup>, the USVs of WT pups peaked around postnatal day 6 (P6) to P8 and stopped around P14 (<xref ref-type="fig" rid="F2">Figure 2l</xref>). KI-HOM pups, however, emitted significantly fewer USVs on P2, P4, and P6. Interestingly, on P14, while most WT pups stopped emitting USVs, KI-HOM pups continued to do so. This is not due to eye-opening defects as both WT and KI-HOM pups opened their eyes around P13-P14. These data suggest that USV development is altered in KI-HOM mice.</p>
<p id="P21">We also performed open field assay and rotarod to evaluate motor function; elevated plus maze to evaluate anxiety; self-grooming and marble burying to evaluate repetitive behaviors; acoustic startle and prepulse inhibition to evaluate sensory-gating; adult USV to evaluate social communication in the adult. All have previously been shown to be abnormal in <italic>Shank3</italic> null mice <sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. We did not observe any difference between WT and KI mice in these tests (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 5a-j</xref> and <xref ref-type="supplementary-material" rid="SD6">Supplementary Table 6</xref>). Together, these results show that loss of Shank3-ABI interaction causes abnormal social behavior/social communication that mimic a subset of phenotypes found in mice heterozygous or homozygous for <italic>Shank3</italic> null alleles <sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>.</p>
</sec>
<sec id="S8">
<title>Shank3-ABI interaction is critical for dendritic spine development and synaptic transmission</title>
<p id="P22">To understand how disruption of Shank3-ABI interaction impairs neuronal function at a cellular level, we first investigated the functional relationship between Shank3 and ABIs in dendritic spine development. Loss of either ABI1 or ABI2 leads to reduced spine maturation and spine density <sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup>, similar to the effect of <italic>Shank3</italic> deficiency <sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup>. We created distinct lines of mouse dissociated hippocampal neurons, either overexpressing Shank3, depleting <italic>Abi1/Abi2</italic> using siRNAs, or combining the two (<xref ref-type="fig" rid="F3">Figure 3a</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 6a</xref>). Analysis of the morphology of dendritic spines revealed that knock down of <italic>Abi1</italic> and <italic>Abi2</italic> decreased stubby spine, mushroom-like spine (mature form), and total spine densities (<xref ref-type="fig" rid="F3">Figure 3a,b</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 6b</xref>). Overexpression of Shank3 increased stubby spine, mushroom-like spine, and total spine densities, but concurrent Shank3 overexpression and <italic>Abi1/Abi2</italic> depletion resulted in a spine morphology that was indistinguishable from <italic>Abi1/Abi2</italic> depletion alone. These results demonstrate that ABIs are downstream of Shank3 in spine development.</p>
<p id="P23">Next, the necessity of the Shank3-ABI protein interaction for Shank3’s function in spine development was assayed using a molecular replacement method. Neurons from <italic>Shank3B</italic> KO mice <sup><xref ref-type="bibr" rid="R13">13</xref></sup> had a greater number of immature thin spines and fewer mushroom-like spines (<xref ref-type="fig" rid="F3">Figure 3c,d</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 6c</xref>). Overexpression of WT Shank3 in <italic>Shank3B</italic> KO neurons rescued all the altered spine characteristics and further increased the number of stubby spines, mushroom-like spines, and total spines compared with WT neurons. In contrast, both S685I and S685A Shank3 failed to rescue the decreased mushroom-like spines. These data indicate that Shank3 interaction with ABI requires phosphorylation at S685, which, in turn, is necessary for Shank3 to promote mushroom-like, more mature spine formation.</p>
<p id="P24">Conversely, the role of the Shank3-ABI interaction for ABI’s function in spine formation was assayed. To test this, the residues critical for ABI to bind Shank3 were identified. Based on the structure of the ABI2 SH3 domain (PDB: 2ED0) and sequence homology search with HHpred <sup><xref ref-type="bibr" rid="R45">45</xref></sup> (see <xref ref-type="sec" rid="S2">Methods</xref>), N446 and L461 of ABI2 were predicted to bind S685 of Shank3. We confirmed the importance of these residues for Shank3-ABI interaction by co-immunoprecipitation (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 6d</xref>). Overexpression of WT ABI1 significantly increased stubby spine, mushroom-like spine, and total spine densities (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 6e</xref>). However, overexpression of the Shank3 binding-deficient ABI1 (N447A L462A) failed to increase spine densities of any category, which further confirmed the importance of Shank3-ABI interaction in spine development.</p>
<p id="P25">To test whether these morphological changes translate into functional consequences, we recorded miniature excitatory postsynaptic currents (mEPSCs) in dissociated pyramidal-like hippocampal neurons from WT and <italic>Shank3B</italic> KO mice. Compared with WT neurons, <italic>Shank3B</italic> KO neurons had reduced mEPSC frequency, without significant changes in mEPSC amplitude (<xref ref-type="fig" rid="F3">Figure 3e,f</xref>). This reduction in mEPSC frequency can be rescued by transfecting these neurons with WT Shank3, but not with S685I Shank3, suggesting that Shank3-ABI interaction contributes to the formation of functional synaptic sites.</p>
<p id="P26">To validate these findings <italic>in vivo</italic>, we assessed spine development and synaptic transmission in KI-HOM mice. Because Shank3 is highly expressed in the striatum, and previous reports found both spine development and synaptic transmission deficits in the dorsal striatum of <italic>Shank3</italic> KO mice <sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup>, we quantified dendritic spine densities of medium spiny neurons (MSNs) in the dorsal striatum. KI-HOM mice displayed a significant reduction in spine density (<xref ref-type="fig" rid="F3">Figure 3g</xref>). A reduction in spine density was not observed in hippocampal CA1 pyramidal neurons (<xref ref-type="fig" rid="F3">Figure 3h</xref>), probably due to compensation from Shank2 which is highly expressed in the hippocampus and interacts with ABIs. Recording mEPSCs of MSNs in the dorsal striatum determined that both mEPSC frequency and amplitude are reduced in KI-HOM mice (<xref ref-type="fig" rid="F3">Figure 3i,j</xref>), similar to what has been reported in <italic>Shank3</italic> KO mice <sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. Together, these results indicate that interaction with ABI is critical for Shank3 function in both spine maturation and excitatory synaptic transmission.</p>
</sec>
<sec id="S9">
<title>Shank3-ABI interaction is critical for actin nucleation</title>
<p id="P27">KI-HOM mice have reduced dendritic spines, impaired synaptic transmission, altered social behaviors, but intact motor function and lack repetitive self-grooming, indicating that only a subset of Shank3 function (a module) is mediated by Shank3-ABI interaction. To determine the module Shank3-ABI interaction belongs to, we compared the interactomes of Shank3 and ABI1 to find their shared functional partners. First, we applied a method similar to that which we used to build Shank3 interactome to build an ABI1 interactome consisting of 151 proteins (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 3</xref>). Next, we compared the two interactomes and found significant overlap (<xref ref-type="fig" rid="F4">Figure 4a</xref>; Fisher’s exact test, <italic>p</italic> = 2.11 × 10<sup>−13</sup>, odds ratio = 6.21). Gene ontology analysis of the 31 common interactors suggested that regulation of the Arp2/3 complex and actin nucleation may be one of their principal functions (<xref ref-type="fig" rid="F4">Figure 4b</xref> and <xref ref-type="supplementary-material" rid="SD7">Supplementary Table 7</xref>).</p>
<p id="P28">To pinpoint the specific roles of Shank3 and ABI1 in the actin nucleation pathway, we integrated the two interactomes to generate a sub-network of actin-related proteins (<xref ref-type="fig" rid="F4">Figure 4c</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 2</xref>, <xref ref-type="supplementary-material" rid="SD3">3</xref>, and <xref ref-type="supplementary-material" rid="SD4">4</xref>). Most components of the Arp2/3-mediated actin nucleation pathway were found in the network. Rho GTPases such as RAC1 and CDC42 activate nucleation-promoting factors (NPF) such as WRC and N-WASP, which then activate the Arp2/3 complex to initiate actin nucleation and branching <sup><xref ref-type="bibr" rid="R46">46</xref></sup>. Cortactin is another type of NPF that facilitates Arp2/3 activation <sup><xref ref-type="bibr" rid="R46">46</xref></sup>. As shown in the network, Shank3 binds the Arp2/3 complex, its upstream regulators (Rho GTPases, WRC, cortactin), and its downstream effector actin, potentially serving as a hub for actin nucleation. In contrast, ABI1, as a subunit of WRC, interacts with other WRC components (WAVE1/2/3, CYFIP1/2, NCKAP1, BRK1) and cortactin but not with the Arp2/3 complex itself. Thus, ABI1 might participate in actin nucleation in a supercomplex centered on Shank3. Consistent with this, size-exclusion chromatography showed that some ABI1 and WAVE1 were present in the same high-molecular-weight fraction (fraction 8) as the Shank3-GKAP-PSD-95 complex (<xref ref-type="fig" rid="F4">Figure 4d</xref>).</p>
<p id="P29">To test if the Shank3-ABI1 interaction is critical for actin nucleation, we stained F-actin in rat primary hippocampal neurons overexpressing either WT or S685I Shank3. Overexpression of WT Shank3 greatly increased F-actin intensity in dendritic spines, but overexpression of the ABI1 binding-deficient S685I Shank3 had a minimum if any effect on F-actin intensity (<xref ref-type="fig" rid="F4">Figure 4e,f</xref>). Together, these results define ABI1-dependent actin nucleation as a module of Shank3 function.</p>
</sec>
<sec id="S10">
<title>Shank3 recruits WRC to the PSD via ABI1 to promote spine maturation</title>
<p id="P30">Finally, we investigated the molecular mechanism by which Shank3-ABI1 interaction promotes actin nucleation in dendritic spines. Because ABI1 is the only subunit of the WRC that has previously been shown to directly bind Shank3 <sup><xref ref-type="bibr" rid="R10">10</xref></sup>, we hypothesized that it mediates the interaction between Shank3 and WAVE/WRC. To test this possibility, we performed co-immunoprecipitation assays between Shank3 and WAVE1 in HEK293T cells. Consistent with our hypothesis, S685I Shank3, which disables interaction with ABI1, also abolished Shank3 binding to WAVE1 (<xref ref-type="fig" rid="F5">Figure 5a</xref>). In a complementary experiment, a WAVE1 mutant, whose binding to ABI1 was abolished by two amino acid changes <sup><xref ref-type="bibr" rid="R33">33</xref></sup>, failed to interact with Shank3 (<xref ref-type="fig" rid="F5">Figure 5b</xref>). We also tested the interaction between Shank3 and WAVE3, another WAVE family protein that is, like WAVE1, enriched in brain and localized at dendritic spines <sup><xref ref-type="bibr" rid="R47">47</xref></sup>. Disruption of Shank3-ABI1 interaction also abolished Shank3 binding to WAVE3 (<xref ref-type="fig" rid="F5">Figure 5c</xref>).</p>
<p id="P31">Given that ABI1 mediates Shank3-WRC interaction, it is conceivable that Shank3 promotes F-actin formation in dendritic spines by recruiting ABI1 and its associated WRC into spines to activate Arp2/3. To test this possibility, we overexpressed Shank3 in rat hippocampal neurons and stained endogenous ABI1 to quantify its localization. Contrary to our hypothesis, Shank3 overexpression did not change the enrichment of ABI1 in dendritic spines (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 7a,b</xref>). The spine localization of ABI1 was also preserved in <italic>Shank3B</italic> KO neurons (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 7c,d</xref>). These results indicate that ABI1 localization to spines might be independent of Shank3.</p>
<p id="P32">Since both Shank3 and ABI1 are expressed at the tip of the spine in the post-synaptic density or PSD, which occupies ~10% of the surface area of spine <sup><xref ref-type="bibr" rid="R48">48</xref></sup>, Shank3 could interact with, recruit, and stabilize ABI1 and WRC to the PSD from other parts of the dendritic spine. Indeed, in the striatal PSD fraction from <italic>Shank3B</italic> KO mice, but not in the total homogenate, the abundance of ABI1 was dramatically lower than in WT (<xref ref-type="fig" rid="F5">Figure 5d,e</xref>). WAVE1 was also lower in the PSD of <italic>Shank3B</italic> KO mice. We noticed that PSD-95 abundance was also slightly reduced, which implies a change in the PSD architecture upon loss of Shank3. Thus, it is possible that reduced WRC in the PSD is caused by some secondary effects other than loss of Shank3-ABI1 interaction. To rule out this possibility, we performed PSD fractionation on striatal tissues from KI-HOM mice. Again, we found that ABI1 and WAVE1 abundances were reduced in the PSD, but not in the total homogenate of KI-HOM mice (<xref ref-type="fig" rid="F5">Figure 5f,g</xref>). Note that both Shank3 and PSD-95 abundances in the PSD fraction of KI-HOM mice remain unchanged, indicating their proper localization and intact PSD organization. These results demonstrate that recruitment of WRC to the PSD requires Shank3-ABI1 interaction.</p>
<p id="P33">To determine if WRC-dependent actin nucleation mediates the effect of Shank3 on spine maturation, we either overexpressed Shank3, depleted <italic>Wave1/Wave3</italic> using siRNAs (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 7e,f</xref>), or combined the two in dissociated hippocampal neurons and then analyzed the morphology of spines. Similar to <italic>Abi1/Abi2</italic> depletion, <italic>Wave1/Wave3</italic> depletion completely abolished the effect of Shank3 overexpression (<xref ref-type="fig" rid="F5">Figure 5h,i</xref> and <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 7g</xref>), demonstrating that WAVE proteins are also critical downstream effectors for Shank3.</p>
</sec>
</sec>
<sec id="S11">
<title>DISCUSSION</title>
<p id="P34">This study was initiated to identify critical protein interactions and downstream effectors of Shank3 for its function at the synapse. By combining protein interaction domain data, post-translational modification data, and ASD exome sequencing data, we discovered a residue of Shank3 critical for its interaction with ABI1 that is mutated in autism. We further validated ABI1/WRC as a <italic>bona fide</italic>, direct downstream effector of Shank3 <italic>in vivo</italic>. Shank3 recruits WRC to the PSD through phosphorylation-dependent interaction with ABI1 to facilitate actin nucleation and spine development, disruption of which impairs synaptic transmission and multiple social behaviors (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 7h</xref>). The most critical finding is that the S685I mutation, which specifically disables Shank3 to promote actin nucleation, only causes a subset of phenotypes found in constitutive <italic>Shank3</italic> KO condition. This sort of functional and phenotypic modularity was unexpected.</p>
<sec id="S12">
<title>Phosphorylation-dependent regulation of Shank3</title>
<p id="P35">We explored Shank3 phosphorylation pattern <italic>in vivo</italic> and found that it is extensively phosphorylated at dozens of residues. As phosphorylation can rapidly modulate a protein’s function by altering its stability, subcellular localization, or protein interactions, our work provides a valuable resource for future studies on the post-translational regulation of Shank3 in spine remodeling and synaptic plasticity. It is worth mentioning that the phosphorylation sites were identified on the full-length isoform of Shank3. Whether other Shank3 isoforms are phosphorylated on the same residues requires further investigation.</p>
<p id="P36">In this study, we focused on one specific <italic>in vivo</italic> phosphorylation site S685, because of its importance for the Shank3-ABI interaction. Because this interaction is essential for Shank3 function and S685A Shank3 failed to promote mature spine formation, S685 phosphorylation might serve as a mechanism to finely tune Shank3 function in actin nucleation at the PSD during spine maturation. We showed that PKA phosphorylates S685 and that inhibition of PKA decreased Shank3-ABI interaction in neurons. The involvement of PKA in Shank3 regulation is interesting, as short-term activation of PKA increases both spine size and spine density in hippocampal neurons <sup><xref ref-type="bibr" rid="R49">49</xref>,<xref ref-type="bibr" rid="R50">50</xref></sup>. Our data suggest that Shank3 phosphorylation at S685 facilitate WRC recruitment and rapid actin cytoskeleton reorganization in dendritic spines upon activation of PKA signaling.</p>
</sec>
<sec id="S13">
<title>Shank3 as a hub for actin nucleation necessary for spine development</title>
<p id="P37">The role of Shank3 in spine development is well-known. Although Shank3 has long been proposed to regulate actin <sup><xref ref-type="bibr" rid="R51">51</xref></sup>, whether Shank3 promotes spine development through regulating actin cytoskeleton has not been established, especially <italic>in vivo</italic>. We show that ABI and WAVE, both known to primarily function as actin nucleation regulators, are downstream effectors of Shank3 in spine development. Moreover, the S685I mutation, which specifically disables Shank3 for actin nucleation while does not affect its other interactions, abundance or PSD localization, still causes spine defects <italic>in vivo</italic>. Together, these results demonstrate that Shank3 function in spine development largely relies on its actin nucleation module. Based on our integrated interactome analysis, Shank3 might serve as a hub in the deeper layer of the PSD, bringing together NPFs and Arp2/3 to cooperatively facilitate actin nucleation.</p>
<p id="P38">The involvement of Shank3 in actin nucleation and the association of the S685I variant with autism indicate a critical role of actin nucleation in the pathogenesis of <italic>SHANK3</italic> deficiency. Beyond that, dysregulation of actin nucleation could be a general mechanism underlying autism spectrum disorders. Supporting this idea, <italic>de novo</italic> mutations in <italic>NCKAP1</italic> and <italic>ABI2</italic>, which encode WRC subunits, have been linked to autism <sup><xref ref-type="bibr" rid="R52">52</xref></sup>. Moreover, copy number variation of <italic>CYFIP1</italic>, which encodes another WRC subunit, has been linked to both autism spectrum disorder and schizophrenia <sup><xref ref-type="bibr" rid="R53">53</xref>–<xref ref-type="bibr" rid="R55">55</xref></sup>. Further human genetic studies to explore genes critical for actin dynamics might prove fruitful in identifying new etiologies for autism or other neurodevelopmental disorders. Detailed studies of how variation in these genes contribute to pathology will undoubtedly provide insights into not only mechanisms of the disease, but also the regulation of actin dynamics and its role in synaptogenesis.</p>
</sec>
<sec id="S14">
<title>The S685I missense mutation demonstrates the modularity of Shank3 function</title>
<p id="P39">While displaying increased social dominance, increased allogrooming, and delayed USV development, our <italic>Shank3</italic> KI mice do not express all the phenotypes reported in <italic>Shank3</italic> KO mice. For example, motor defects, increased anxiety, abnormal self-grooming behaviors, and altered sensory gating that were repeatedly reported in <italic>Shank3</italic> KO lines <sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>, are intact in KI mice, suggesting that they are mediated by other protein interactions/pathways. These results are consistent with previous findings that targeting <italic>Shank3</italic> at different domains leads to different sets of physiological and behavioral abnormalities <sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R25">25</xref>–<xref ref-type="bibr" rid="R27">27</xref></sup>. This modularity further indicates that there is more than one independent pathogenic pathway downstream of Shank3 and correcting a single downstream pathway is unlikely to be sufficient for clear clinical improvement. An example similar to this is Rett syndrome where targeting the downstream dysregulated BDNF through IGF-1 only partially rescued Rett phenotypes <sup><xref ref-type="bibr" rid="R56">56</xref></sup>. Thus, rather than attempting to correct downstream deficits, it might be more fruitful to identify upstream regulators of dosage-dependent genes in neuropsychiatric disorders for therapeutic targeting.</p>
<p id="P40">Our study also highlights the value of missense variants in understanding the pathogenesis of neuropsychiatric disorders. Most mutations found in genome sequencing studies are missense mutations of unknown significance. While they are often less informative for identifying new neuropsychiatric disease-causing genes, missense mutations could lead to a greater understanding of protein functions that are linked to the disease. The difficulty lies in distinguishing informative missense mutations from non-pathogenic ones. Our strategy was to map missense variants onto post-translational modification sites and protein interaction domains to identify potentially critical residues. This approach could be used for other neuropsychiatric disease-causing genes to gain additional insight into mechanisms of the disease.</p>
</sec>
</sec>
<sec id="SM1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Sup Table 1</label>
<media id="d36e1202" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_1.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD10">
<label>Supp info</label>
<media id="d36e1206" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Supp_info.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD11">
<label>Video 1</label>
<media id="d36e1210" mimetype="video" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Video_1.mp4" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD12">
<label>Video 2</label>
<media id="d36e1214" mimetype="video" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Video_2.mp4" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Sup Table 2</label>
<media id="d36e1218" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_2.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Sup Table 3</label>
<media id="d36e1222" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_3.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Sup Table 4</label>
<media id="d36e1226" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_4.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>Sup Table 5</label>
<media id="d36e1230" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_5.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>Sup Table 6</label>
<media id="d36e1234" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_6.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>Sup Table 7</label>
<media id="d36e1238" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_7.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD8">
<label>Sup Table 8</label>
<media id="d36e1243" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Sup_Table_8.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD9">
<label>Supp figs</label>
<media id="d36e1247" orientation="portrait" position="anchor" xlink:href="NIHMS1512779-supplement-Supp_figs.pdf" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S15">
<title>ACKNOWLEDGMENTS</title>
<p id="P41">We are grateful to Gabriele Schuster for injection of <italic>Shank3</italic> BAC; Yousuf O. Ali and Hui-Chen Lu for technical input on primary neuron culture; Antrix Jain and Sung Y. Jung for their help in mass spectrometry; Dinghui Yu for his help in imaging data analysis; Vicky Brandt, Aya Ito-Ishida, Callison E. Alcott, and Vincenzo A. Gennarino for editorial input. This work was supported by the Howard Hughes Medical Institute (to H.Y.Z.), a gift from Mr. Charif Souki (to the Jan and Dan Duncan Neurological Research Institute), a grant (1R01GM097207) from the National Institute of Health (to P.B.), and a supercomputer allocation (MCB120101) from XSEDE (to P.B.). The work was also supported in part by IDDRC grant number 1U54 HD083092 from the Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development. IDDRC Neurobehavior and Neurovisualization cores were used for this project. L.W. was supported by a predoctoral fellowship from Autism Speaks (#9120). J.L.H. was supported by an NINDS K08 Award (NS091381), the Robbins Foundation, Baylor Pediatrics Pilot Award, as well as Chao Physician-Scientist Award.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement" id="FN1">
<p id="P42">CONFLICT OF INTERESTS</p>
<p id="P43">The authors declare no conflict of interests.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCE</title>
<ref id="R1">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Leblond</surname><given-names>CS</given-names></name>, <name><surname>Nava</surname><given-names>C</given-names></name>, <name><surname>Polge</surname><given-names>A</given-names></name>, <name><surname>Gauthier</surname><given-names>J</given-names></name>, <name><surname>Huguet</surname><given-names>G</given-names></name>, <name><surname>Lumbroso</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments</article-title>. <source/>PLoS Genet
<year>2014</year>; <volume>10</volume>: <fpage>e1004580</fpage>.<pub-id pub-id-type="pmid">25188300</pub-id></mixed-citation>
</ref>
<ref id="R2">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Moessner</surname><given-names>R</given-names></name>, <name><surname>Marshall</surname><given-names>CR</given-names></name>, <name><surname>Sutcliffe</surname><given-names>JS</given-names></name>, <name><surname>Skaug</surname><given-names>J</given-names></name>, <name><surname>Pinto</surname><given-names>D</given-names></name>, <name><surname>Vincent</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Contribution of SHANK3 mutations to autism spectrum disorder</article-title>. <source/>Am J Hum Genet
<year>2007</year>; <volume>81</volume>: <fpage>1289</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">17999366</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>CM</given-names></name>, <name><surname>Betancur</surname><given-names>C</given-names></name>, <name><surname>Boeckers</surname><given-names>TM</given-names></name>, <name><surname>Bockmann</surname><given-names>J</given-names></name>, <name><surname>Chaste</surname><given-names>P</given-names></name>, <name><surname>Fauchereau</surname><given-names>F</given-names></name>
<etal></etal>
<article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>. <source/>Nat Genet
<year>2007</year>; <volume>39</volume>: <fpage>25</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>X-L</given-names></name>, <name><surname>Towers</surname><given-names>A</given-names></name>, <name><surname>Cao</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>P</given-names></name>
<etal></etal>
<article-title>Epigenetic Dysregulation of SHANK3 in Brain Tissues from Individuals with Autism Spectrum Disorders</article-title>. <source/>Hum Mol Genet
<year>2013</year>; : <fpage>1</fpage>–<lpage>50</lpage>.</mixed-citation>
</ref>
<ref id="R5">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Cochoy</surname><given-names>DM</given-names></name>, <name><surname>Kolevzon</surname><given-names>A</given-names></name>, <name><surname>Kajiwara</surname><given-names>Y</given-names></name>, <name><surname>Schoen</surname><given-names>M</given-names></name>, <name><surname>Pascual-Lucas</surname><given-names>M</given-names></name>, <name><surname>Lurie</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID</article-title>. <source/>Mol Autism
<year>2015</year>; <volume>6</volume>: <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">25705365</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Phelan</surname><given-names>K</given-names></name>, <name><surname>McDermid</surname><given-names>HE</given-names></name>. <article-title>The 22q13.3 deletion syndrome (Phelan-McDermid syndrome)</article-title>. <source/>Mol Syndromol
<year>2012</year>; <volume>2</volume>: <fpage>186</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">22670140</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Naisbitt</surname><given-names>S</given-names></name>, <name><surname>Eunjoon</surname><given-names>K</given-names></name>, <name><surname>Tu</surname><given-names>JC</given-names></name>, <name><surname>Xiao</surname><given-names>B</given-names></name>, <name><surname>Sala</surname><given-names>C</given-names></name>, <name><surname>Valtschanoff</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</article-title>. <source/>Neuron
<year>1999</year>; <volume>23</volume>: <fpage>569</fpage>–<lpage>582</lpage>.<pub-id pub-id-type="pmid">10433268</pub-id></mixed-citation>
</ref>
<ref id="R8">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Tu</surname><given-names>JC</given-names></name>, <name><surname>Xiao</surname><given-names>B</given-names></name>, <name><surname>Naisbitt</surname><given-names>S</given-names></name>, <name><surname>Yuan</surname><given-names>JP</given-names></name>, <name><surname>Petralia</surname><given-names>RS</given-names></name>, <name><surname>Brakeman</surname><given-names>P</given-names></name>
<etal></etal>
<article-title>Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</article-title>. <source/>Neuron
<year>1999</year>; <volume>23</volume>: <fpage>583</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">10433269</pub-id></mixed-citation>
</ref>
<ref id="R9">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Bockmann</surname><given-names>J</given-names></name>, <name><surname>Kreutz</surname><given-names>MR</given-names></name>, <name><surname>Gundelfinger</surname><given-names>ED</given-names></name>, <name><surname>Böckers</surname><given-names>TM</given-names></name>. <article-title>ProSAP/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53</article-title>. <source/>J Neurochem
<year>2002</year>; <volume>83</volume>: <fpage>1013</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">12421375</pub-id></mixed-citation>
</ref>
<ref id="R10">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Proepper</surname><given-names>C</given-names></name>, <name><surname>Johannsen</surname><given-names>S</given-names></name>, <name><surname>Liebau</surname><given-names>S</given-names></name>, <name><surname>Dahl</surname><given-names>J</given-names></name>, <name><surname>Vaida</surname><given-names>B</given-names></name>, <name><surname>Bockmann</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation</article-title>. <source/>EMBO J
<year>2007</year>; <volume>26</volume>: <fpage>1397</fpage>–<lpage>409</lpage>.<pub-id pub-id-type="pmid">17304222</pub-id></mixed-citation>
</ref>
<ref id="R11">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Meyer</surname><given-names>G</given-names></name>, <name><surname>Varoqueaux</surname><given-names>F</given-names></name>, <name><surname>Neeb</surname><given-names>A</given-names></name>, <name><surname>Oschlies</surname><given-names>M</given-names></name>, <name><surname>Brose</surname><given-names>N</given-names></name>. <article-title>The complexity of PDZ domain-mediated interactions at glutamatergic synapses: A case study on neuroligin</article-title>. <source/>Neuropharmacology
<year>2004</year>; <volume>47</volume>: <fpage>724</fpage>–<lpage>733</lpage>.<pub-id pub-id-type="pmid">15458844</pub-id></mixed-citation>
</ref>
<ref id="R12">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Grabrucker</surname><given-names>AM</given-names></name>, <name><surname>Knight</surname><given-names>MJ</given-names></name>, <name><surname>Proepper</surname><given-names>C</given-names></name>, <name><surname>Bockmann</surname><given-names>J</given-names></name>, <name><surname>Joubert</surname><given-names>M</given-names></name>, <name><surname>Rowan</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation</article-title>. <source/>EMBO J
<year>2011</year>; <volume>30</volume>: <fpage>569</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">21217644</pub-id></mixed-citation>
</ref>
<ref id="R13">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Peça</surname><given-names>J</given-names></name>, <name><surname>Feliciano</surname><given-names>C</given-names></name>, <name><surname>Ting</surname><given-names>JT</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Wells</surname><given-names>MF</given-names></name>, <name><surname>Venkatraman</surname><given-names>TN</given-names></name>
<etal></etal>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>. <source/>Nature
<year>2011</year>; <volume>472</volume>: <fpage>437</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="R14">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>McCoy</surname><given-names>P a</given-names></name>, <name><surname>Rodriguiz</surname><given-names>RM</given-names></name>, <name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Je</surname><given-names>HS</given-names></name>, <name><surname>Roberts</surname><given-names>AC</given-names></name> et al. <article-title>Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3</article-title>. <source/>Hum Mol Genet
<year>2011</year>; <volume>20</volume>: <fpage>3093</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">21558424</pub-id></mixed-citation>
</ref>
<ref id="R15">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Bey</surname><given-names>AL</given-names></name>, <name><surname>Katz</surname><given-names>BM</given-names></name>, <name><surname>Badea</surname><given-names>A</given-names></name>, <name><surname>Kim</surname><given-names>N</given-names></name>, <name><surname>David</surname><given-names>LK</given-names></name>
<etal></etal>
<article-title>Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism</article-title>. <source/>Nat Commun
<year>2016</year>; <volume>7</volume>: <fpage>11459</fpage>.<pub-id pub-id-type="pmid">27161151</pub-id></mixed-citation>
</ref>
<ref id="R16">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Bozdagi</surname><given-names>O</given-names></name>, <name><surname>Sakurai</surname><given-names>T</given-names></name>, <name><surname>Papapetrou</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Dickstein</surname><given-names>DL</given-names></name>, <name><surname>Takahashi</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication</article-title>. <source/>Mol Autism
<year>2010</year>; <volume>1</volume>: <fpage>15</fpage>.<pub-id pub-id-type="pmid">21167025</pub-id></mixed-citation>
</ref>
<ref id="R17">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>K</given-names></name>, <name><surname>Holder</surname><given-names>JL</given-names><suffix>Jr</suffix></name>, <name><surname>Schaaf</surname><given-names>CP</given-names></name>, <name><surname>Lu</surname><given-names>H-C</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Kang</surname><given-names>H</given-names></name>
<etal></etal>
<article-title>SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties</article-title>. <source/>Nature
<year>2013</year>; <volume>503</volume>: <fpage>72</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">24153177</pub-id></mixed-citation>
</ref>
<ref id="R18">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Roussignol</surname><given-names>G</given-names></name>, <name><surname>Ango</surname><given-names>F</given-names></name>, <name><surname>Romorini</surname><given-names>S</given-names></name>, <name><surname>Tu</surname><given-names>JC</given-names></name>, <name><surname>Sala</surname><given-names>C</given-names></name>, <name><surname>Worley</surname><given-names>PF</given-names></name>
<etal></etal>
<article-title>Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons</article-title>. <source/>J Neurosci
<year>2005</year>; <volume>25</volume>: <fpage>3560</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">15814786</pub-id></mixed-citation>
</ref>
<ref id="R19">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>CM</given-names></name>, <name><surname>Perroy</surname><given-names>J</given-names></name>, <name><surname>Loll</surname><given-names>F</given-names></name>, <name><surname>Perrais</surname><given-names>D</given-names></name>, <name><surname>Fagni</surname><given-names>L</given-names></name>, <name><surname>Bourgeron</surname><given-names>T</given-names></name>
<etal></etal>
<article-title>SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism</article-title>. <source/>Mol Psychiatry
<year>2012</year>; <volume>17</volume>: <fpage>71</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">21606927</pub-id></mixed-citation>
</ref>
<ref id="R20">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Mei</surname><given-names>Y</given-names></name>, <name><surname>Monteiro</surname><given-names>P</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>J-A</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Fu</surname><given-names>Z</given-names></name>
<etal></etal>
<article-title>Adult restoration of Shank3 expression rescues selective autistic-like phenotypes</article-title>. <source/>Nature
<year>2016</year>; <volume>530</volume>: <fpage>481</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">26886798</pub-id></mixed-citation>
</ref>
<ref id="R21">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Kaiser</surname><given-names>T</given-names></name>, <name><surname>Monteiro</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Van der Goes</surname><given-names>MS</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects</article-title>. <source/>Neuron
<year>2016</year>; <volume>89</volume>: <fpage>147</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">26687841</pub-id></mixed-citation>
</ref>
<ref id="R22">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Arons</surname><given-names>MH</given-names></name>, <name><surname>Thynne</surname><given-names>CJ</given-names></name>, <name><surname>Grabrucker</surname><given-names>AM</given-names></name>, <name><surname>Li</surname><given-names>D</given-names></name>, <name><surname>Schoen</surname><given-names>M</given-names></name>, <name><surname>Cheyne</surname><given-names>JE</given-names></name>
<etal></etal>
<article-title>Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling</article-title>. <source/>J Neurosci
<year>2012</year>; <volume>32</volume>: <fpage>14966</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">23100419</pub-id></mixed-citation>
</ref>
<ref id="R23">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Kouser</surname><given-names>M</given-names></name>, <name><surname>Speed</surname><given-names>HE</given-names></name>, <name><surname>Dewey</surname><given-names>CM</given-names></name>, <name><surname>Reimers</surname><given-names>JM</given-names></name>, <name><surname>Widman</surname><given-names>AJ</given-names></name>, <name><surname>Gupta</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>Loss of predominant shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission</article-title>. <source/>J Neurosci
<year>2013</year>; <volume>33</volume>: <fpage>18448</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">24259569</pub-id></mixed-citation>
</ref>
<ref id="R24">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Verpelli</surname><given-names>C</given-names></name>, <name><surname>Dvoretskova</surname><given-names>E</given-names></name>, <name><surname>Vicidomini</surname><given-names>C</given-names></name>, <name><surname>Rossi</surname><given-names>F</given-names></name>, <name><surname>Chiappalone</surname><given-names>M</given-names></name>, <name><surname>Schoen</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses</article-title>. <source/>J Biol Chem
<year>2011</year>; <volume>286</volume>: <fpage>34839</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">21795692</pub-id></mixed-citation>
</ref>
<ref id="R25">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Speed</surname><given-names>HE</given-names></name>, <name><surname>Kouser</surname><given-names>M</given-names></name>, <name><surname>Xuan</surname><given-names>Z</given-names></name>, <name><surname>Reimers</surname><given-names>JM</given-names></name>, <name><surname>Ochoa</surname><given-names>CF</given-names></name>, <name><surname>Gupta</surname><given-names>N</given-names></name>
<etal></etal>
<source/>Autism-Associated Insertion Mutation ( InsG ) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits. <year>2015</year>; <volume>35</volume>: <fpage>9648</fpage>–<lpage>9665</lpage>.</mixed-citation>
</ref>
<ref id="R26">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Jaramillo</surname><given-names>TC</given-names></name>, <name><surname>Speed</surname><given-names>HE</given-names></name>, <name><surname>Xuan</surname><given-names>Z</given-names></name>, <name><surname>Reimers</surname><given-names>JM</given-names></name>, <name><surname>Escamilla</surname><given-names>CO</given-names></name>, <name><surname>Weaver</surname><given-names>TP</given-names></name>
<etal></etal>
<article-title>Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function</article-title>. <source/>Autism Res
<year>2017</year>; <volume>10</volume>: <fpage>42</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">27492494</pub-id></mixed-citation>
</ref>
<ref id="R27">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Jaramillo</surname><given-names>TC</given-names></name>, <name><surname>Speed</surname><given-names>HE</given-names></name>, <name><surname>Xuan</surname><given-names>Z</given-names></name>, <name><surname>Reimers</surname><given-names>JM</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Powell</surname><given-names>CM</given-names></name>. <article-title>Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4–9 Deletion Mouse Model of Autism</article-title>. <source/>Autism Res
<year>2016</year>; <volume>9</volume>: <fpage>350</fpage>–<lpage>375</lpage>.<pub-id pub-id-type="pmid">26559786</pub-id></mixed-citation>
</ref>
<ref id="R28">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Vicidomini</surname><given-names>C</given-names></name>, <name><surname>Ponzoni</surname><given-names>L</given-names></name>, <name><surname>Lim</surname><given-names>D</given-names></name>, <name><surname>Schmeisser</surname><given-names>MJ</given-names></name>, <name><surname>Reim</surname><given-names>D</given-names></name>, <name><surname>Morello</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice</article-title>. <source/>Mol Psychiatry
<year>2017</year>; <volume>22</volume>: <fpage>689</fpage>–<lpage>702</lpage>.<pub-id pub-id-type="pmid">27021819</pub-id></mixed-citation>
</ref>
<ref id="R29">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Bidinosti</surname><given-names>M</given-names></name>, <name><surname>Botta</surname><given-names>P</given-names></name>, <name><surname>Kruttner</surname><given-names>S</given-names></name>, <name><surname>Proenca</surname><given-names>CC</given-names></name>, <name><surname>Stoehr</surname><given-names>N</given-names></name>, <name><surname>Bernhard</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency</article-title>. <source/>Science
<year>2016</year>; <volume>351</volume>: <fpage>1199</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">26847545</pub-id></mixed-citation>
</ref>
<ref id="R30">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Yi</surname><given-names>F</given-names></name>, <name><surname>Danko</surname><given-names>T</given-names></name>, <name><surname>Botelho</surname><given-names>SC</given-names></name>, <name><surname>Patzke</surname><given-names>C</given-names></name>, <name><surname>Pak</surname><given-names>C</given-names></name>, <name><surname>Wernig</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons</article-title>. <source/>Science
<year>2016</year>; <volume>352</volume>: <fpage>aaf2669</fpage>.<pub-id pub-id-type="pmid">26966193</pub-id></mixed-citation>
</ref>
<ref id="R31">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Duffney</surname><given-names>LJ</given-names></name>, <name><surname>Zhong</surname><given-names>P</given-names></name>, <name><surname>Wei</surname><given-names>J</given-names></name>, <name><surname>Matas</surname><given-names>E</given-names></name>, <name><surname>Cheng</surname><given-names>J</given-names></name>, <name><surname>Qin</surname><given-names>L</given-names></name>
<etal></etal>
<article-title>Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators</article-title>. <source/>Cell Rep
<year>2015</year>; : <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="R32">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>GM</given-names></name>, <name><surname>Rumbaugh</surname><given-names>GR</given-names></name>, <name><surname>Harrar</surname><given-names>DB</given-names></name>, <name><surname>Huganir</surname><given-names>RL</given-names></name>. <article-title>Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2005</year>; <volume>102</volume>: <fpage>15006</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">16217014</pub-id></mixed-citation>
</ref>
<ref id="R33">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Borek</surname><given-names>D</given-names></name>, <name><surname>Padrick</surname><given-names>SB</given-names></name>, <name><surname>Gomez</surname><given-names>TS</given-names></name>, <name><surname>Metlagel</surname><given-names>Z</given-names></name>, <name><surname>Ismail</surname><given-names>AM</given-names></name>
<etal></etal>
<article-title>Structure and control of the actin regulatory WAVE complex</article-title>. <source/>Nature
<year>2010</year>; <volume>468</volume>: <fpage>533</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21107423</pub-id></mixed-citation>
</ref>
<ref id="R34">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Kennelly</surname><given-names>PJ</given-names></name>, <name><surname>Krebs</surname><given-names>EG</given-names></name>. <article-title>Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases</article-title>. <source/>J Biol Chem
<year>1991</year>; <volume>266</volume>: <fpage>15555</fpage>–<lpage>15558</lpage>.<pub-id pub-id-type="pmid">1651913</pub-id></mixed-citation>
</ref>
<ref id="R35">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Goldberg</surname><given-names>AP</given-names></name>, <name><surname>Poultney</surname><given-names>CS</given-names></name>, <name><surname>Samocha</surname><given-names>K</given-names></name>, <name><surname>Ercument Cicek</surname><given-names>A</given-names></name>
<etal></etal>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<year>2014</year>; <volume>515</volume>: <fpage>209</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="R36">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>., <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>
<etal></etal>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature
<year>2016</year>; <volume>536</volume>: <fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="R37">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>
<etal></etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods
<year>2010</year>; <volume>7</volume>: <fpage>248</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="R38">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>P</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>, <name><surname>Ng</surname><given-names>PC</given-names></name>. <article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>. <source/>Nat Protoc
<year>2009</year>; <volume>4</volume>: <fpage>1073</fpage>–<lpage>1081</lpage>.<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
</ref>
<ref id="R39">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Fyffe</surname><given-names>SL</given-names></name>, <name><surname>Neul</surname><given-names>JL</given-names></name>, <name><surname>Samaco</surname><given-names>RC</given-names></name>, <name><surname>Chao</surname><given-names>HT</given-names></name>, <name><surname>Ben-Shachar</surname><given-names>S</given-names></name>, <name><surname>Moretti</surname><given-names>P</given-names></name>
<etal></etal>
<article-title>Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to Stress</article-title>. <source/>Neuron
<year>2008</year>; <volume>59</volume>: <fpage>947</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">18817733</pub-id></mixed-citation>
</ref>
<ref id="R40">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Brodkin</surname><given-names>ES</given-names></name>, <name><surname>Goforth</surname><given-names>SA</given-names></name>, <name><surname>Keene</surname><given-names>AH</given-names></name>, <name><surname>Fossella</surname><given-names>JA</given-names></name>, <name><surname>Silver</surname><given-names>LM</given-names></name>. <article-title>Identification of quantitative trait Loci that affect aggressive behavior in mice</article-title>. <source/>J Neurosci
<year>2002</year>; <volume>22</volume>: <fpage>1165</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">11826145</pub-id></mixed-citation>
</ref>
<ref id="R41">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Kessels</surname><given-names>HW</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>. <article-title>The mouse that roared: Neural mechanisms of social hierarchy</article-title>. <source/>Trends Neurosci
<year>2014</year>; <volume>37</volume>: <fpage>674</fpage>–<lpage>682</lpage>.<pub-id pub-id-type="pmid">25160682</pub-id></mixed-citation>
</ref>
<ref id="R42">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Zhu</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Lin</surname><given-names>Z</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>. <article-title>Bidirectional control of social hierarchy by synaptic efficacy in medial prefrontal cortex</article-title>. <source/>Science
<year>2011</year>; <volume>334</volume>: <fpage>693</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">21960531</pub-id></mixed-citation>
</ref>
<ref id="R43">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Hamilton</surname><given-names>SM</given-names></name>, <name><surname>Spencer</surname><given-names>CM</given-names></name>, <name><surname>Harrison</surname><given-names>WR</given-names></name>, <name><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name><surname>Graham</surname><given-names>DF</given-names></name>, <name><surname>Daza</surname><given-names>RAM</given-names></name>
<etal></etal>
<article-title>Multiple autism-like behaviors in a novel transgenic mouse model</article-title>. <source/>Behav Brain Res
<year>2011</year>; <volume>218</volume>: <fpage>29</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">21093492</pub-id></mixed-citation>
</ref>
<ref id="R44">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Grove</surname><given-names>M</given-names></name>, <name><surname>Demyanenko</surname><given-names>G</given-names></name>, <name><surname>Echarri</surname><given-names>A</given-names></name>, <name><surname>Zipfel</surname><given-names>PA</given-names></name>, <name><surname>Quiroz</surname><given-names>ME</given-names></name>, <name><surname>Rodriguiz</surname><given-names>RM</given-names></name>
<etal></etal>
<article-title>Abi2-Deficient Mice Exhibit Defective Cell Migration, Aberrant Dendritic Spine Morphogenesis, and Deficits in Learning and Memory</article-title>. <source/>Mol Cell Biol
<year>2004</year>; <volume>24</volume>: <fpage>10905</fpage>–<lpage>10922</lpage>.<pub-id pub-id-type="pmid">15572692</pub-id></mixed-citation>
</ref>
<ref id="R45">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Söding</surname><given-names>J</given-names></name>
<article-title>Protein homology detection by HMM-HMM comparison</article-title>. <source/>Bioinformatics
<year>2005</year>; <volume>21</volume>: <fpage>951</fpage>–<lpage>960</lpage>.<pub-id pub-id-type="pmid">15531603</pub-id></mixed-citation>
</ref>
<ref id="R46">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Goley</surname><given-names>ED</given-names></name>, <name><surname>Welch</surname><given-names>MD</given-names></name>. <article-title>The ARP2/3 complex: an actin nucleator comes of age</article-title>. <source/>Nat Rev Mol Cell Biol
<year>2006</year>; <volume>7</volume>: <fpage>713</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">16990851</pub-id></mixed-citation>
</ref>
<ref id="R47">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Pilpel</surname><given-names>Y</given-names></name>, <name><surname>Segal</surname><given-names>M</given-names></name>. <article-title>Rapid WAVE dynamics in dendritic spines of cultured hippocampal neurons is mediated by actin polymerization</article-title>. <source/>J Neurochem
<year>2005</year>; <volume>95</volume>: <fpage>1401</fpage>–<lpage>1410</lpage>.<pub-id pub-id-type="pmid">16190876</pub-id></mixed-citation>
</ref>
<ref id="R48">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Hering</surname><given-names>H</given-names></name>, <name><surname>Sheng</surname><given-names>M</given-names></name>. <article-title>Dendritic spines: structure, dynamics and regulation</article-title>. <source/>Nat Rev Neurosci
<year>2001</year>; <volume>2</volume>: <fpage>880</fpage>–<lpage>888</lpage>.<pub-id pub-id-type="pmid">11733795</pub-id></mixed-citation>
</ref>
<ref id="R49">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Pöschel</surname><given-names>B</given-names></name>, <name><surname>Faul</surname><given-names>C</given-names></name>, <name><surname>Upreti</surname><given-names>C</given-names></name>, <name><surname>Stanton</surname><given-names>PK</given-names></name>, <name><surname>Mundel</surname><given-names>P</given-names></name>. <article-title>Essential role for synaptopodin in dendritic spine plasticity of the developing hippocampus</article-title>. <source/>J Neurosci
<year>2013</year>; <volume>33</volume>: <fpage>12510</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">23884954</pub-id></mixed-citation>
</ref>
<ref id="R50">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Zha</surname><given-names>XM</given-names></name>, <name><surname>Kim</surname><given-names>EY</given-names></name>, <name><surname>Schachtele</surname><given-names>S</given-names></name>, <name><surname>Dailey</surname><given-names>ME</given-names></name>, <name><surname>Hall</surname><given-names>DD</given-names></name>
<etal></etal>
<article-title>A Kinase Anchor Protein 150 (AKAP150)-associated protein kinase A limits dendritic spine density</article-title>. <source/>J Biol Chem
<year>2011</year>; <volume>286</volume>: <fpage>26496</fpage>–<lpage>26506</lpage>.<pub-id pub-id-type="pmid">21652711</pub-id></mixed-citation>
</ref>
<ref id="R51">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Sarowar</surname><given-names>T</given-names></name>, <name><surname>Grabrucker</surname><given-names>AM</given-names></name>. <article-title>Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies</article-title>. <source/>Neural Plast
<year>2016</year>; <volume>2016</volume>: <fpage>1</fpage>–<lpage>15</lpage>.</mixed-citation>
</ref>
<ref id="R52">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Iossifov</surname><given-names>I</given-names></name>, <name><surname>O’Roak</surname><given-names>BJ</given-names></name>, <name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>Ronemus</surname><given-names>M</given-names></name>, <name><surname>Krumm</surname><given-names>N</given-names></name>, <name><surname>Levy</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>. <source/>Nature
<year>2014</year>; <volume>515</volume>: <fpage>216</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="R53">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Stefansson</surname><given-names>H</given-names></name>, <name><surname>Rujescu</surname><given-names>D</given-names></name>, <name><surname>Cichon</surname><given-names>S</given-names></name>, <name><surname>Pietiläinen</surname><given-names>OPH</given-names></name>, <name><surname>Ingason</surname><given-names>A</given-names></name>, <name><surname>Steinberg</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Large recurrent microdeletions associated with schizophrenia</article-title>. <source/>Nature
<year>2008</year>; <volume>455</volume>: <fpage>232</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">18668039</pub-id></mixed-citation>
</ref>
<ref id="R54">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Leblond</surname><given-names>CS</given-names></name>, <name><surname>Heinrich</surname><given-names>J</given-names></name>, <name><surname>Delorme</surname><given-names>R</given-names></name>, <name><surname>Proepper</surname><given-names>C</given-names></name>, <name><surname>Betancur</surname><given-names>C</given-names></name>, <name><surname>Huguet</surname><given-names>G</given-names></name>
<etal></etal>
<article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders</article-title>. <source/>PLoS Genet
<year>2012</year>; <volume>8</volume>: <fpage>e1002521</fpage>.<pub-id pub-id-type="pmid">22346768</pub-id></mixed-citation>
</ref>
<ref id="R55">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Tam</surname><given-names>GWC</given-names></name>, <name><surname>van de Lagemaat</surname><given-names>LN</given-names></name>, <name><surname>Redon</surname><given-names>R</given-names></name>, <name><surname>Strathdee</surname><given-names>KE</given-names></name>, <name><surname>Croning</surname><given-names>MDR</given-names></name>, <name><surname>Malloy</surname><given-names>MP</given-names></name>
<etal></etal>
<article-title>Confirmed rare copy number variants implicate novel genes in schizophrenia</article-title>. <source/>Biochem Soc Trans
<year>2010</year>; <volume>38</volume>: <fpage>445</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">20298200</pub-id></mixed-citation>
</ref>
<ref id="R56">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Tropea</surname><given-names>D</given-names></name>, <name><surname>Giacometti</surname><given-names>E</given-names></name>, <name><surname>Wilson</surname><given-names>NR</given-names></name>, <name><surname>Beard</surname><given-names>C</given-names></name>, <name><surname>McCurry</surname><given-names>C</given-names></name>, <name><surname>Fu</surname><given-names>DD</given-names></name>
<etal></etal>
<article-title>Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice</article-title>. <source/>Proc Natl Acad Sci
<year>2009</year>; <volume>106</volume>: <fpage>2029</fpage>–<lpage>2034</lpage>.<pub-id pub-id-type="pmid">19208815</pub-id></mixed-citation>
</ref>
<ref id="R57">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Warming</surname><given-names>S</given-names></name>, <name><surname>Costantino</surname><given-names>N</given-names></name>, <name><surname>Court</surname><given-names>DL</given-names></name>, <name><surname>Jenkins</surname><given-names>NA</given-names></name>, <name><surname>Copeland</surname><given-names>NG</given-names></name>. <article-title>Simple and highly efficient BAC recombineering using galK selection</article-title>. <source/>Nucleic Acids Res
<year>2005</year>; <volume>33</volume>: <fpage>e36</fpage>.<pub-id pub-id-type="pmid">15731329</pub-id></mixed-citation>
</ref>
<ref id="R58">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>Z</given-names></name>, <name><surname>Dudek</surname><given-names>H</given-names></name>, <name><surname>Miranti</surname><given-names>CK</given-names></name>, <name><surname>Greenberg</surname><given-names>ME</given-names></name>. <article-title>Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism</article-title>. <source/>J Neurosci
<year>1996</year>; <volume>16</volume>: <fpage>5425</fpage>–<lpage>5436</lpage>.<pub-id pub-id-type="pmid">8757255</pub-id></mixed-citation>
</ref>
<ref id="R59">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Sakai</surname><given-names>Y</given-names></name>, <name><surname>Shaw</surname><given-names>C a</given-names></name>, <name><surname>Dawson</surname><given-names>BC</given-names></name>, <name><surname>Dugas</surname><given-names>DV</given-names></name>, <name><surname>Al-Mohtaseb</surname><given-names>Z</given-names></name>, <name><surname>Hill</surname><given-names>DE</given-names></name>
<etal></etal>
<article-title>Protein interactome reveals converging molecular pathways among autism disorders</article-title>. <source/>Sci Transl Med
<year>2011</year>; <volume>3</volume>: <fpage>86ra49</fpage>.</mixed-citation>
</ref>
<ref id="R60">
<label>60</label>
<mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>MH</given-names></name>, <name><surname>Seeburg</surname><given-names>D</given-names></name>, <name><surname>Seo</surname><given-names>J</given-names></name>, <name><surname>Verpelli</surname><given-names>C</given-names></name>, <name><surname>Han</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD</article-title>. <source/>PLoS Biol
<year>2009</year>; <volume>7</volume>: <fpage>e100018</fpage>.</mixed-citation>
</ref>
<ref id="R61">
<label>61</label>
<mixed-citation publication-type="journal"><name><surname>MacLean</surname><given-names>B</given-names></name>, <name><surname>Tomazela</surname><given-names>DM</given-names></name>, <name><surname>Shulman</surname><given-names>N</given-names></name>, <name><surname>Chambers</surname><given-names>M</given-names></name>, <name><surname>Finney</surname><given-names>GL</given-names></name>, <name><surname>Frewen</surname><given-names>B</given-names></name>
<etal></etal>
<article-title>Skyline: An open source document editor for creating and analyzing targeted proteomics experiments</article-title>. <source/>Bioinformatics
<year>2010</year>; <volume>26</volume>: <fpage>966</fpage>–<lpage>968</lpage>.<pub-id pub-id-type="pmid">20147306</pub-id></mixed-citation>
</ref>
<ref id="R62">
<label>62</label>
<mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>CM</given-names></name>, <name><surname>Alekseyenko</surname><given-names>O</given-names></name>, <name><surname>Serysheva</surname><given-names>E</given-names></name>, <name><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name><surname>Paylor</surname><given-names>R</given-names></name>. <article-title>Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome</article-title>. <source/>Genes, Brain Behav
<year>2005</year>; <volume>4</volume>: <fpage>420</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">16176388</pub-id></mixed-citation>
</ref>
<ref id="R63">
<label>63</label>
<mixed-citation publication-type="journal"><name><surname>Janz</surname><given-names>JM</given-names></name>, <name><surname>Sakmar</surname><given-names>TP</given-names></name>, <name><surname>Min</surname><given-names>KC</given-names></name>. <article-title>A novel interaction between atrophin-interacting protein 4 and β-p21-activated kinase-interactive exchange factor is mediated by an SH3 domain</article-title>. <source/>J Biol Chem
<year>2007</year>; <volume>282</volume>: <fpage>28893</fpage>–<lpage>28903</lpage>.<pub-id pub-id-type="pmid">17652093</pub-id></mixed-citation>
</ref>
<ref id="R64">
<label>64</label>
<mixed-citation publication-type="journal"><name><surname>Ghose</surname><given-names>R</given-names></name>, <name><surname>Shekhtman</surname><given-names>A</given-names></name>, <name><surname>Goger</surname><given-names>MJ</given-names></name>, <name><surname>Ji</surname><given-names>H</given-names></name>, <name><surname>Cowburn</surname><given-names>D</given-names></name>. <article-title>A novel, specific interaction involving the Csk SH3 domain and its natural ligand</article-title>. <source/>Nat Struct Biol
<year>2001</year>; <volume>8</volume>: <fpage>998</fpage>–<lpage>1004</lpage>.<pub-id pub-id-type="pmid">11685249</pub-id></mixed-citation>
</ref>
<ref id="R65">
<label>65</label>
<mixed-citation publication-type="journal"><name><surname>Corominas</surname><given-names>R</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Lin</surname><given-names>GN</given-names></name>, <name><surname>Kang</surname><given-names>S</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Ghamsari</surname><given-names>L</given-names></name>
<etal></etal>
<article-title>Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism</article-title>. <source/>Nat Commun
<year>2014</year>; <volume>5</volume>: <fpage>3650</fpage>.<pub-id pub-id-type="pmid">24722188</pub-id></mixed-citation>
</ref>
<ref id="R66">
<label>66</label>
<mixed-citation publication-type="journal"><name><surname>Razick</surname><given-names>S</given-names></name>, <name><surname>Magklaras</surname><given-names>G</given-names></name>, <name><surname>Donaldson</surname><given-names>IM</given-names></name>. <article-title>iRefIndex: a consolidated protein interaction database with provenance</article-title>. <source/>BMC Bioinformatics
<year>2008</year>; <volume>9</volume>: <fpage>405</fpage>.<pub-id pub-id-type="pmid">18823568</pub-id></mixed-citation>
</ref>
<ref id="R67">
<label>67</label>
<mixed-citation publication-type="journal"><name><surname>Bayés</surname><given-names>A</given-names></name>, <name><surname>van de Lagemaat</surname><given-names>LN</given-names></name>, <name><surname>Collins</surname><given-names>MO</given-names></name>, <name><surname>Croning</surname><given-names>MDR</given-names></name>, <name><surname>Whittle</surname><given-names>IR</given-names></name>, <name><surname>Choudhary</surname><given-names>JS</given-names></name>
<etal></etal>
<article-title>Characterization of the proteome, diseases and evolution of the human postsynaptic density</article-title>. <source/>Nat Neurosci
<year>2011</year>; <volume>14</volume>: <fpage>19</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">21170055</pub-id></mixed-citation>
</ref>
<ref id="R68">
<label>68</label>
<mixed-citation publication-type="journal"><name><surname>Bayés</surname><given-names>À</given-names></name>, <name><surname>Collins</surname><given-names>MO</given-names></name>, <name><surname>Croning</surname><given-names>MDR</given-names></name>, <name><surname>van de Lagemaat</surname><given-names>LN</given-names></name>, <name><surname>Choudhary</surname><given-names>JS</given-names></name>, <name><surname>Grant</surname><given-names>SGN</given-names></name>. <article-title>Comparative Study of Human and Mouse Postsynaptic Proteomes Finds High Compositional Conservation and Abundance Differences for Key Synaptic Proteins</article-title>. <source/>PLoS One
<year>2012</year>; <volume>7</volume>: <fpage>e46683</fpage>.<pub-id pub-id-type="pmid">23071613</pub-id></mixed-citation>
</ref>
<ref id="R69">
<label>69</label>
<mixed-citation publication-type="journal"><name><surname>Shannon</surname><given-names>P</given-names></name>, <name><surname>Markiel</surname><given-names>A</given-names></name>, <name><surname>Ozier</surname><given-names>O</given-names></name>, <name><surname>Baliga</surname><given-names>NS</given-names></name>, <name><surname>Wang</surname><given-names>JT</given-names></name>, <name><surname>Ramage</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source/>Genome Res
<year>2005</year>; <volume>13</volume>: <fpage>2498</fpage>–<lpage>2504</lpage>.</mixed-citation>
</ref>
<ref id="R70">
<label>70</label>
<mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Hochberg</surname><given-names>Y</given-names></name>. <article-title>Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing</article-title>. <source/>J R Stat Soc
<year>1995</year>; <volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
</ref>
<ref id="R71">
<label>71</label>
<mixed-citation publication-type="journal"><name><surname>Lam</surname><given-names>YC</given-names></name>, <name><surname>Bowman</surname><given-names>AB</given-names></name>, <name><surname>Jafar-Nejad</surname><given-names>P</given-names></name>, <name><surname>Lim</surname><given-names>J</given-names></name>, <name><surname>Richman</surname><given-names>R</given-names></name>, <name><surname>Fryer</surname><given-names>JD</given-names></name>
<etal></etal>
<article-title>ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology</article-title>. <source/>Cell
<year>2006</year>; <volume>127</volume>: <fpage>1335</fpage>–<lpage>1347</lpage>.<pub-id pub-id-type="pmid">17190598</pub-id></mixed-citation>
</ref>
<ref id="R72">
<label>72</label>
<mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>J</given-names></name>, <name><surname>Crespo-Barreto</surname><given-names>J</given-names></name>, <name><surname>Jafar-Nejad</surname><given-names>P</given-names></name>, <name><surname>Bowman</surname><given-names>AB</given-names></name>, <name><surname>Richman</surname><given-names>R</given-names></name>, <name><surname>Hill</surname><given-names>DE</given-names></name>
<etal></etal>
<article-title>Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1</article-title>. <source/>Nature
<year>2008</year>; <volume>452</volume>: <fpage>713</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">18337722</pub-id></mixed-citation>
</ref>
<ref id="R73">
<label>73</label>
<mixed-citation publication-type="journal"><name><surname>Um</surname><given-names>K</given-names></name>, <name><surname>Niu</surname><given-names>S</given-names></name>, <name><surname>Duman</surname><given-names>JG</given-names></name>, <name><surname>Cheng</surname><given-names>JX</given-names></name>, <name><surname>Tu</surname><given-names>YK</given-names></name>, <name><surname>Schwechter</surname><given-names>B</given-names></name>
<etal></etal>
<article-title>Dynamic Control of Excitatory Synapse Development by a Rac1 GEF/GAP Regulatory Complex</article-title>. <source/>Dev Cell
<year>2014</year>; <volume>29</volume>: <fpage>701</fpage>–<lpage>715</lpage>.<pub-id pub-id-type="pmid">24960694</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p id="P44">S685 phosphorylation modulates Shank3-ABI interaction. (<bold>a</bold>) Diagram of Shank3 protein (NP_067398) with 41 <italic>in vivo</italic> phosphorylated residues identified by mass spectrometry. (<bold>b</bold>) Diagram of Shank3 protein with S685 (green highlighted) adjacent to a previously identified ABI1 binding site (red text) on Shank3. (<bold>c</bold>) Protein sequence alignment of Shank3 surrounding S685 among vertebrates. (<bold>d</bold>,<bold>e</bold>) Immunoblots of ABI1-GFP (<bold>d</bold>) or ABI2-GFP (<bold>e</bold>) and HA-Shank3 following immunoprecipitation of HA-Shank3 variants in the co-immunoprecipitation assay in 293T cells (n=6, n=6 experiments). (<bold>f</bold>) Percentage of peptides with S685 phosphorylation in Shank3 mass-spectrometry-based <italic>in vitro</italic> kinase assay by ERK2, PKAα, GSK3β, and CK2. (<bold>g</bold>) Immunoblots of PKA α-catalytic subunit following immunoprecipitation of EGFP-tagged Shank3 from <italic>EGFP-Shank3</italic> transgenic mice striatal lysate. TG, <italic>EGFP-Shank3</italic> transgenic mice. (<bold>h</bold>) <italic>In vitro</italic> kinase assay with radiolabeled ATP using recombinant PKAα and Shank3 peptides including S685. Left, coomassie blue staining of BSA-conjugated peptides (aa 668–691). Right, autoradiography blot of kinase reaction product. (<bold>i</bold>) Immunoprecipitation of ABI1 in primary cortical neurons treated with vehicle (DMSO) or H89 (10 μM) followed by immunoblotting for Shank3, WAVE1, and ABI1 (n=4 experiments). WAVE1-ABI1 co-immunoprecipitation was used as positive control. Veh, vehicle (DMSO). All data are presented as mean ± s.e.m. *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01; paired two-tailed Student’s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="nihms-1512779-f0001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p id="P45">The autism-linked Shank3 S685I mutation specifically diminishes Shank3-ABI interaction and causes selective social phenotypes. (<bold>a</bold>,<bold>b</bold>) Immunoblots of ABI1-GFP (<bold>a</bold>) or ABI2-GFP (<bold>b</bold>) and HA-Shank3 following immunoprecipitation of HA-Shank3 variants in the co-immunoprecipitation assay in 293T cells (n=4, n=4 experiments). (<bold>c</bold>) Schematic diagram for S685I KI mice generation by CRISPR/Cas9. Top: single strand oligodeoxynucleotides used as a repair template; red: codon encoding isoleucine; blue: synonymous mutation for genotyping. Middle: genomic sequence spanning Shank3 S685; green: codon encoding S685; scissors: Cas9 cutting site. Bottom: structure of wild-type mouse <italic>Shank3</italic> gene. (<bold>d</bold>) Sequencing chromatograms of the S685I allele. (<bold>e</bold>,<bold>f</bold>) Immunoprecipitation of ABI1 in cortical (<bold>e</bold>) or striatal (<bold>f</bold>) lysate of KI-HET or KI-HOM mice followed by immunoblotting for Shank3, WAVE1, and ABI1 (n=3, n=3 experiments). (<bold>g</bold>) Time spent sniffing or allogrooming the intruder C57 mice in the resident-intruder assay (n=10, 13 mice). (<bold>h</bold>) Number of mounting events on the intruder C57 mice in the resident-intruder assay (n=10, 13 mice). (<bold>i</bold>) Time spent attacking or biting the intruder C57 mice in the resident-intruder assay (n=10, 13 mice). (<bold>j</bold>) Time spent allogrooming the intruder A/J mice in the resident-intruder assay (n=20, 8, 14 mice). (<bold>k</bold>) Percentage of wins in test pairs between indicated genotypes in the tube test (n=36, 32, 30, 24 matches). (<bold>l</bold>) Number of ultrasonic calls from pups separated from their dams (n=53, 26, 27 pups). All data are presented as mean ± s.e.m. *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, ****<italic>p</italic>&lt;0.0001, NS, not significant; (<bold>a</bold>,<bold>b</bold>) paired two-tailed Student’s <italic>t</italic>-test; (<bold>e</bold>,<bold>f</bold>) paired and unpaired two-tailed Student’s <italic>t</italic>-test; (<bold>g</bold>,<bold>h</bold>) unpaired two-tailed Student’s <italic>t</italic>-test; (<bold>i</bold>) Mann-Whitney <italic>U</italic> test; (<bold>j</bold>) Kruskal-Wallis test with <italic>post hoc</italic> Dunn’s test; (<bold>k</bold>) two-tailed binomial test; (<bold>l</bold>) two-way ANOVA with <italic>post hoc</italic> Tukey’s tests.</p>
</caption>
<graphic xlink:href="nihms-1512779-f0002"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p id="P46">Shank3-ABI interaction is critical for dendritic spine development and synaptic transmission. (<bold>a</bold>) Fluorescent images of dendrites from days <italic>in vitro</italic> (DIV) 14 dissociated mouse hippocampal neurons co-transfected with siRNAs (scramble or against mouse <italic>Abi1</italic> and <italic>Abi2</italic>), pEGFP-C1 plasmids and vectors expressing HA-Shank3 (empty or WT) on DIV 7. Scale bar, 5μm; OE, overexpression. (<bold>b</bold>) Quantification of dendritic spine densities in <bold>a</bold> (n=19, 15, 15, 15 neurons). (<bold>c</bold>) Fluorescent images of dendrites from DIV 14 dissociated mouse hippocampal neurons (WT or <italic>Shank3B</italic> KO) transfected with pEGFP-C1 plasmids and vectors expressing HA-Shank3 (empty, WT, S685I, or S685A) on DIV 7. Scale bar, 5μm. OE, overexpression. (<bold>d</bold>) Quantification of dendritic spine densities in <bold>c</bold> (n=32, 22, 18, 20, 15 neurons). (<bold>e</bold>) Typical mEPSC recordings of DIV 12–16 primary hippocampal neurons from WT or <italic>Shank3B</italic> KO mice transfected with pEGFP-C1 plasmids and vectors expressing HA-Shank3 (empty, WT or S685I). (<bold>f</bold>) Quantification of mEPSC frequency and amplitude in <bold>e</bold> (n=12, 16, 9, 14 neurons). (<bold>g</bold>) Representative images and quantification of spine densities of dorsal striatal medium spiny neurons of mice with indicated genotypes (n=30, 30 neurons). Scale bar, 5μm. (<bold>h</bold>) Representative images and quantification of spine densities of hippocampal CA1 pyramidal neurons of mice with indicated genotypes (n=30, 30 neurons). Scale bar, 5μm. (<bold>i</bold>) Typical mEPSC recordings of dorsal striatal medium spiny neurons from WT or KI-HOM mice. (<bold>j</bold>) Quantification of mEPSC frequency and amplitude in <bold>h</bold> (n=13, 15 neurons). All data are presented as mean ± s.e.m. *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, ****<italic>p</italic>&lt;0.0001, NS, not significant; (<bold>b</bold>,<bold>f</bold>) one-way ANOVA with <italic>post hoc</italic> Tukey’s tests; (<bold>d</bold>) one-way ANOVA with <italic>post hoc</italic> Dunnett’s tests (multiple comparisons were carried against WT group as control); (<bold>g,h</bold>) unpaired two-tailed Student’s <italic>t</italic>-test; (<bold>j</bold>) Mann-Whitney <italic>U</italic> test.</p>
</caption>
<graphic xlink:href="nihms-1512779-f0003"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p id="P47">Shank3 and ABI1 functions converge on actin nucleation. (<bold>a</bold>) Venn diagrams showing the overlap between Shank3 interactome and ABI1 interactome. (<bold>b</bold>) Gene ontology analysis of the intersection of Shank3 and ABI1 interactomes. (<bold>c</bold>) Actin cytoskeleton-related sub-network of the Shank3-ABI1 interactome. Green nodes indicate Shank3 specific interactors, blue nodes indicate ABI1 specific interactors, and red nodes indicate the shared interactors between Shank3 and ABI1. Green edges indicate interactions within the Shank3 specific interactors, blue edges indicate interactions within the ABI1 specific interactors, red edges indicate interactions associated with the shared interactors, and gray edges indicate interactions between the Shank3 specific interactors and the ABI1 specific interactors. (<bold>d</bold>) Immunoblots following size-exclusion chromatography of mouse striatal lysate. V0, void volume; *, non-specific band. (<bold>e</bold>) Fluorescent images of dendrites from DIV 21 dissociated rat hippocampal neurons transfected with pEGFP-C1 plasmids and vectors expressing HA-Shank3 (empty, WT, or S685I) on DIV 6. Scale bar, 5μm. OE, overexpression. (<bold>f</bold>) Quantification of normalized integrated spine F-actin intensity in <bold>e</bold> (n=22, 22, 22 neurons). OE, overexpression. All data are presented as mean ± s.e.m. **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, NS, not significant; (<bold>f</bold>) one-way ANOVA with <italic>post hoc</italic> Tukey’s tests</p>
</caption>
<graphic xlink:href="nihms-1512779-f0004"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p id="P48">Shank3 recruits WRC to the PSD via ABI1 to promote spine development. (<bold>a</bold>) Immunoblots of GFP-WAVE1 and HA-Shank3 following immunoprecipitation of HA-Shank3 variants in the co-immunoprecipitation assay in 293T cells. (b) Immunoblots of GFP-WAVE1 variants and HA-Shank3 following immunoprecipitation of HA-Shank3 in the co-immunoprecipitation assay in 293T cells. (c) Immunoblots of GFP-WAVE3 and HA-Shank3 following immunoprecipitation of HA-Shank3 variants in the co-immunoprecipitation assay in 293T cells. (<bold>d</bold>) Immunoblots following PSD fractionation using WT or <italic>Shank3B</italic> KO mice striatal lysate. PSD-95 and Shank3 were used as positive controls for each fraction. S1, supernatant 1; P2’, crude synaptosomal fraction; P3, membrane fraction; SPM, synaptic plasma membrane; PSD I, SPM after one-time Triton X-100 washout. (<bold>e</bold>) Quantifications of immunoblots in <bold>d</bold> (n=3 experiments). (<bold>f</bold>) Immunoblots following PSD fractionation using WT or KI-HOM mice striatal lysate. (<bold>g</bold>) Quantifications of immunoblots in <bold>f</bold> (n=3 experiments). (<bold>h</bold>) Fluorescent images of dendrites from DIV 14 dissociated mouse hippocampal neurons co-transfected with siRNAs (scramble or against mouse <italic>Wave1</italic> and <italic>Wave3</italic>), pEGFP-C1 plasmids and vectors expressing HA-Shank3 (empty or WT) on DIV 7. Scale bar, 5μm; OE, overexpression. (<bold>i</bold>) Quantification of dendritic spine densities in <bold>h</bold> (n=16, 23, 24, 30 neurons). All data are presented as mean ± s.e.m. *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, ****<italic>p</italic>&lt;0.0001, NS, not significant; (<bold>e</bold>,<bold>g</bold>) paired two-tailed Student’s <italic>t</italic>-test; (<bold>i</bold>) one-way ANOVA with <italic>post hoc</italic> Tukey’s tests.</p>
</caption>
<graphic xlink:href="nihms-1512779-f0005"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>